Answers are grounded in this paper and cite their sources.
Three hundred thirty-six medical personnel from hemodialysis centers were treated with three doses, 20 microgram each, of the Merck hepatitis B vaccine (at 0, 1, and 6 months). Within 1 month after the first injection, 41% converted to anti-HBs positivity; after the second injection the conversion rate rose to 80-90%; and after the booster, to 96-98%. The later rate remained unchanged during the 18-month follow-up period. Only 2.8% of those vaccinated did not respond to the vaccine. The patterns of immune responses to 20-microgram doses were found to be exactly the same as to 40-microgram doses. It is suggested that reduced doses of vaccine should be as efficacious as the larger ones.
No takes yet. Share an insight, caveat, or question.
Szmuness et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: